DnB Asset Management AS Acquires 148,961 Shares of Bath & Body Works, Inc. $BBWI

Key Points

• DnB Asset Management AS increased its holdings in Bath & Body Works by 15.6%, acquiring an additional 148,961 shares, bringing its total to over 1.1 million shares valued at approximately $33.5 million.
• Several research firms have recently adjusted their price targets for Bath & Body Works, with Citigroup lowering theirs from $42.00 to $40.00 and UBS Group from $36.00 to $32.00, reflecting a cautious outlook.
• Bath & Body Works announced a quarterly dividend of $0.20 per share, representing an annualized yield of 2.5%, to be paid on September 5th.

DnB Asset Management AS grew its holdings in shares of Bath & Body Works, Inc. (NYSE:BBWI - Free Report) by 15.6% in the 1st quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 1,103,791 shares of the company's stock after buying an additional 148,961 shares during the quarter. DnB Asset Management AS owned 0.52% of Bath & Body Works worth $33,467,000 at the end of the most recent quarter.

Several other institutional investors also recently bought and sold shares of the business. SVB Wealth LLC purchased a new position in shares of Bath & Body Works in the first quarter valued at $35,000. Golden State Wealth Management LLC boosted its stake in shares of Bath & Body Works by 94.7% in the first quarter. Golden State Wealth Management LLC now owns 1,320 shares of the company's stock valued at $40,000 after purchasing an additional 642 shares during the period. UMB Bank n.a. raised its holdings in Bath & Body Works by 65.9% in the first quarter. UMB Bank n.a. now owns 1,501 shares of the company's stock valued at $46,000 after acquiring an additional 596 shares in the last quarter. Ancora Advisors LLC acquired a new stake in Bath & Body Works in the fourth quarter valued at $67,000. Finally, GKV Capital Management Co. Inc. acquired a new stake in Bath & Body Works in the first quarter valued at $69,000. 95.14% of the stock is currently owned by hedge funds and other institutional investors.

Bath & Body Works Trading Down 1.2%

BBWI stock traded down $0.35 during mid-day trading on Wednesday, reaching $27.88. 2,217,308 shares of the stock traded hands, compared to its average volume of 5,287,025. Bath & Body Works, Inc. has a 52-week low of $24.94 and a 52-week high of $41.87. The company has a market cap of $5.75 billion, a P/E ratio of 8.27, a P/E/G ratio of 0.98 and a beta of 1.49. The stock's fifty day moving average is $30.63 and its 200-day moving average is $30.36.

Bath & Body Works (NYSE:BBWI - Get Free Report) last issued its quarterly earnings data on Thursday, August 28th. The company reported $0.37 earnings per share for the quarter, meeting the consensus estimate of $0.37. The firm had revenue of $1.55 billion for the quarter, compared to analyst estimates of $1.55 billion. Bath & Body Works had a net margin of 9.88% and a negative return on equity of 48.43%. The company's revenue for the quarter was down .8% on a year-over-year basis. During the same quarter last year, the firm earned $0.37 earnings per share. Bath & Body Works has set its Q3 2025 guidance at 0.370-0.45 EPS. FY 2025 guidance at 3.350-3.600 EPS. Equities research analysts expect that Bath & Body Works, Inc. will post 3.3 earnings per share for the current year.

Bath & Body Works Dividend Announcement

The business also recently disclosed a quarterly dividend, which was paid on Friday, September 5th. Stockholders of record on Friday, August 22nd were paid a $0.20 dividend. The ex-dividend date was Friday, August 22nd. This represents a $0.80 annualized dividend and a dividend yield of 2.9%. Bath & Body Works's dividend payout ratio (DPR) is presently 23.74%.

Wall Street Analysts Forecast Growth

A number of brokerages have weighed in on BBWI. JPMorgan Chase & Co. increased their target price on shares of Bath & Body Works from $40.00 to $46.00 and gave the stock an "overweight" rating in a report on Monday, July 28th. Barclays increased their target price on shares of Bath & Body Works from $30.00 to $32.00 and gave the stock an "equal weight" rating in a report on Friday, August 29th. UBS Group dropped their price objective on shares of Bath & Body Works from $36.00 to $32.00 and set a "neutral" rating on the stock in a report on Friday, August 29th. Wells Fargo & Company increased their price objective on shares of Bath & Body Works from $40.00 to $44.00 and gave the stock an "overweight" rating in a report on Wednesday, May 14th. Finally, Citigroup dropped their price objective on shares of Bath & Body Works from $42.00 to $40.00 and set a "buy" rating on the stock in a report on Tuesday, August 19th. Twelve research analysts have rated the stock with a Buy rating and three have issued a Hold rating to the stock. Based on data from MarketBeat.com, the company currently has an average rating of "Moderate Buy" and a consensus target price of $41.62.

Bath & Body Works Company Profile

Bath & Body Works, Inc is a specialty retailers and home to America's Favorite Fragrances, offering a breadth of exclusive fragrances for the body and home, including the selling collections for fine fragrance mist, body lotion and body cream, 3-wick candles, home fragrance diffusers and liquid hand soap.